Classical Indications Are Useful for Initiating Continuous Renal Replacement Therapy in Critically Ill Patients

被引:3
|
作者
Lee, Jeonghwan [1 ]
Cho, Jang-Hee [2 ]
Chung, Byung Ha [3 ]
Park, Jung Tak [4 ]
Lee, Jung Pyo [5 ]
Chang, Jae Hyun [6 ]
Kim, Dong Ki [7 ]
Kim, Sejoong [8 ]
机构
[1] Hallym Univ, Hangang Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea
[2] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea
[3] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea
[6] Gachon Univ Med & Sci, Dept Internal Med, Inchon, South Korea
[7] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea
来源
基金
新加坡国家研究基金会;
关键词
acute kidney injury; continuous renal replacement therapy; indication; mortality; renal replacement therapy; ACUTE KIDNEY INJURY; GLOMERULAR-FILTRATION-RATE; INTENSIVE-CARE-UNIT; CONSENSUS CONFERENCE; SERUM CREATININE; FAILURE; DIALYSIS; OUTCOMES; EQUATION; DISEASE;
D O I
10.1620/tjem.233.233
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The optimal timing for initiating continuous renal replacement therapy (CRRT) remains controversial, and it is not obvious which parameters should be considered during this process. We investigated the predictive value of physiological parameters among critically ill patients receiving CRRT due to acute kidney injury (AKI). A total of 496 patients who started CRRT were prospectively enrolled. The following physiological parameters were significantly associated with mortality even after multivariate adjustments: level of pH [hazard ratio (95% Cl): 7.15 < pH <= 7.20, 1.971 (1.319-2.946); pH <= 7.15, 2.315 (1.586-3.380); reference > 7.25, P-for-trend < 0.001]; bicarbonate level (HCO3-) [<= 14 mmol/L, 2.010 (1.542-2.620); reference > 18 mmol/L, P-for-trend < 0.001]; phosphorus level [> 7 mmol/L, 1.736 (1.313-2.296); reference <= 5 mmol/L, P-for-trend < 0.001]; and urine output < 0.3 ml/kg/hr [1.509 (1.191-1.912); reference > 0.3 ml/kg/hour]. Weight gain over 2 kg was associated with mortality exclusively according to univariate analysis [1.516 (1.215-1.892)]. The diagnostic value of the composite of these factors (pH, bicarbonate level, phosphorus level, urine output, weight gain, and potassium levels) [area under the curve (AUC) 0.701, 95% Cl 0.644-0.759] was comparable to or higher than the blood urea nitrogen level (AUC 0.571, 95% CI 0.511-0.630), serum creatinine level (AUC 0.462, 95% Cl 0.399-0.525), eGFR (AUG 0.541, 95% Cl 0.478-0.605), and AKI Network stage (AUG 0.627, 95% Cl 0.561-0.692). In conclusion, the physiological parameters are useful in predicting post-AKI mortality and should be considered when initiating CRRT in critically ill patients with AKI.
引用
收藏
页码:233 / 241
页数:9
相关论文
共 50 条
  • [1] Continuous renal replacement therapy in critically ill patients
    Ronco, C
    Bellomo, R
    Ricci, Z
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 67 - 72
  • [2] RECONSIDERATION OF CLASSICAL INDICATION FOR INITIATION OF CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS
    Jeonghwan, Lee
    Ki, Kim Dong
    Young, Ahn Shin
    Jun, Chin Ho
    Young, Na Ki
    Dong-Wan, Chae
    Suk, Han Jin
    Sejoong, Kim
    [J]. NEPHROLOGY, 2014, 19 : 120 - 120
  • [3] A primer on continuous renal replacement therapy for critically ill patients
    Joy, MS
    Matzke, GR
    Armstrong, DK
    Marx, MA
    Zarowitz, BJ
    [J]. ANNALS OF PHARMACOTHERAPY, 1998, 32 (03) : 362 - 375
  • [4] Continuous renal replacement therapy in critically ill pediatric patients
    Zobel, G
    Ring, E
    Rodl, S
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) : S28 - S34
  • [5] Anticoagulation for continuous renal replacement therapy in critically ill patients
    Fernandez-Lorente, L.
    [J]. ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2018, 41 (01) : 131 - 133
  • [6] Should continuous renal replacement therapy be used for 'non-renal' indications in critically ill patients with shock?
    vanBommel, EFH
    [J]. RESUSCITATION, 1997, 33 (03) : 257 - 270
  • [7] Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
    Bellomo, R.
    Cass, A.
    Norton, R.
    Gallagher, M.
    Lo, S.
    Su, S.
    Cole, L.
    Finfer, S.
    McArthur, C.
    McGuinness, S.
    Myburgh, J.
    Scheinkestel, C.
    Bellomo, R.
    Lee, J.
    Ali, D.
    Cass, A.
    Cole, L.
    Finfer, S.
    Gallagher, M.
    Goldsmith, D.
    McGuinness, S.
    Myburgh, J.
    Norton, R.
    Scheinkestel, C.
    Banerjee, A.
    Bhonagiri, D.
    Blythe, D.
    Botha, J.
    Cade, J.
    Cole, L.
    Dobb, G.
    Eddington, J.
    Finfer, S.
    Flabouris, A.
    French, C.
    Garrett, P.
    Henderson, S.
    Ihle, B.
    Joyce, C.
    Kalkoff, M.
    Lipman, J.
    McArthur, C.
    McGuinness, S.
    Milliss, D.
    Mitchell, I.
    Morgan, J.
    Myburgh, J.
    Nair, P.
    Orford, N.
    Raza, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (17): : 1627 - 1638
  • [8] THROMBOCYTOPENIA ASSOCIATED WITH CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS
    Ferreira, Jason
    Johnson, Donald
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [9] Infection in critically ill pediatric patients on continuous renal replacement therapy
    Santiago, Maria J.
    Lopez-Herce, Jesus
    Vierge, Eva
    Castillo, Ana
    Bustinza, Amaya
    Bellon, Jose M.
    Sanchez, Amelia
    Fernandez, Sarah
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2017, 40 (05): : 224 - 229
  • [10] Pharmacokinetics of Caspofungin in Critically Ill Patients on Continuous Renal Replacement Therapy
    Weiler, Stefan
    Seger, Christoph
    Pfisterer, Hartwig
    Stienecke, Eva
    Stippler, Florian
    Welte, Rene
    Joannidis, Michael
    Griesmacher, Andrea
    Bellmann, Romuald
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (08) : 4053 - 4057